Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Review Times Remain A GDUFA II Topic

Executive Summary

Talks continue to include ANDA review times and metrics, increasing potential for more changes.


Related Content

ANDA Submission Wave Continues; Is A Crest Near?
GDUFA II: Inspection Information Takes Center Stage
GDUFA II: FDA Prefers A ‘Manageable Number of High-Impact Changes’
Risk-Based Inspections Might Actually Be Hurting Compliant Firms